Syngen Biotech Market Cap

Syngen Biotech has a market cap or net worth of 3.52 billion as of December 5, 2025. Its market cap has decreased by -4.41% in one year.

Market Cap

3.52B

Enterprise Value

3.52B

Revenue

2.13B

Ranking

n/a

PE Ratio

12.07

Stock Price

130.00

Market Cap Chart

Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 3.52B, an increase of 847.07%. That is a compound annual growth rate of 11.24%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	3.52B	2.36%
Dec 30, 2024	3.44B	-16.45%
Dec 29, 2023	4.12B	-6.17%
Dec 30, 2022	4.39B	43.36%
Dec 30, 2021	3.06B	4.63%
Dec 31, 2020	2.93B	-8.09%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	259.78B
PharmaEssentia	189.73B
Heron Neutron Medical	95.61B
Lotus Pharmaceutical	78.24B
Bora Pharmaceuticals Co., LTD.	65.19B
Lin BioScience	34.45B
Oneness Biotech	33.73B
Lumosa Therapeutics	32.34B

Market Cap Rankings